251. Angiotensin-converting enzymeinhibitors and angiotensin iireceptor blockers synergistically increasecoronary blood flow in canine ischemic myocardium: Role of bradykinin.
- Author
-
Kitakaze, Masafumi, Asanuma, Hiroshi, Funaya, Hiroharu, Node, Koichi, Takashima, Seiji, Sanada, Shoji, Asakura, Masanori, Ogita, Hisakazu, Kim, Jiyoong, and Hori, Masatsugu
- Subjects
- *
ANGIOTENSIN converting enzyme , *ISCHEMIA , *CARDIOMYOPATHIES - Abstract
: ObjectivesWe examined whether the combination of an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin II receptor blocker (ARB) synergistically mediates coronary vasodilation and improves myocardial metabolic and contractile dysfunction in ischemic hearts.: BackgroundEither an ACE inhibitor or ARB mediates coronary vasodilation in ischemic hearts.: MethodsIn dogs with myocardial ischemia, we infused an ACE inhibitor (temocaprilat, 10 μg/kg/min) or ARB (RNH-6270, 10 μg/kg/min) into the coronary artery.: ResultsPerfusion pressure of the left anterior descending coronary artery was reduced from 104 ± 8 to 42 ± 2 mm Hg, so that coronary blood flow (CBF) decreased to one-third of the baseline value. Ten minutes after starting the infusion of temocaprilat, the cardiac bradykinin level increased (from 32 ± 6 to 98 ± 5 pg/ml). Coronary blood flow (29 ± 2 to 44 ± 3 ml/100 g/min) and the cardiac level of nitric oxide (NO) (7.8 ± 1.9 to 17.5 ± 3.2 μm) also increased, with these changes being attenuated by either Nω-nitro-l-arginine methyl ester or HOE140. RNH-6270 alone caused a modest increase in CBF (34 ± 3 ml/100 g/min), with no increase in the cardiac NO or bradykinin levels. Both temocaprilat and RNH-6270 caused a further increase in both CBF (51 ± 4 ml/100 g/min) and cardiac NO levels, without increasing the bradykinin level, and these changes were inhibited by HOE140. In the nonischemic heart, RNH-6270 augmented bradykinin-induced increases in CBF.: ConclusionsThe combination of an ACE inhibitor and ARB mediates greater increases in CBF and more potent cardioprotective effects through bradykinin-dependent mechanisms than either drug alone. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF